• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19

tetano

Editor, Senior Moderator
J Clin Med


. 2024 Apr 20;13(8):2405.
doi: 10.3390/jcm13082405. The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19

Elisabeth Gómez-Moyano[SUP] 1 [/SUP], Javier Pavón-Morón[SUP] 2 3 [/SUP], Jorge Rodríguez-Capitán[SUP] 2 3 [/SUP], Daniel Bardán-Rebollar[SUP] 4 [/SUP], Teresa Ramos-Carrera[SUP] 5 [/SUP], Aurora Villalobos-Sánchez[SUP] 6 [/SUP], Iván Pérez de Pedro[SUP] 6 [/SUP], Francisco J Ruiz-García[SUP] 7 [/SUP], Javier Mora-Robles[SUP] 8 [/SUP], Almudena López-Sampalo[SUP] 6 [/SUP], Miguel A Pérez-Velasco[SUP] 6 [/SUP], Maria-Rosa Bernal-López[SUP] 6 9 [/SUP], Ricardo Gómez-Huelgas[SUP] 6 9 [/SUP], Manuel Jiménez-Navarro[SUP] 2 3 [/SUP], Miguel Romero-Cuevas[SUP] 2 3 [/SUP], Francesco Costa[SUP] 10 [/SUP], Alicia Trenas[SUP] 11 [/SUP], Luis M Pérez-Belmonte[SUP] 3 6 12 [/SUP]



Affiliations
Abstract

The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present post-acute sequelae may display immune dysregulation, a procoagulant state, and persistent microvascular endotheliopathy that could trigger microvascular thrombosis. These elements have also been implicated in the physiopathology of postural orthostatic tachycardia syndrome, a frequent sequela in post-COVID-19 patients. These mechanisms, directly associated with post-acute sequelae, might determine the thrombotic consequences of COVID-19 and the need for early anticoagulation therapy. In this context, heparin has several potential benefits, including immunomodulatory, anticoagulant, antiviral, pro-endothelial, and vascular effects, that could be helpful in the treatment of COVID-19 post-acute sequelae. In this article, we review the evidence surrounding the post-acute sequelae of COVID-19 and the potential benefits of the use of heparin, with a special focus on the treatment of postural orthostatic tachycardia syndrome.

Keywords: COVID-19; heparin; microvascular thrombosis; post-acute sequelae; postural orthostatic tachycardia syndrome.

 
Back
Top Bottom